Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

Galena Biopharma Issues Letter to Shareholders

GlobeNewswire February 14, 2014

Galena Biopharma (GALE) Plunges as Concerns over Scandal Continue

Equities.com February 14, 2014

Catasys Announces Transition to a New Board of Directors

PR Newswire February 13, 2014

Galena Biopharma (GALE) Plummets on Revelation of Potential Stock Promotion Scheme

Equities.com February 12, 2014

Stockhouse @ the Bell: TSX tips up in the morning on job growth figures

Stockhouse Editorial February 10, 2014

Galena Biopharma to Present at the 2014 Leerink Global Healthcare Conference

Globe Newswire February 6, 2014

Galena Biopharma to Present at the 16th Annual BIO CEO & Investor Conference

Globe Newswire February 4, 2014

TrendingWallStreet.com Releases Volume Coverage on HLF, GALE, AEGY, and SING

Accesswire February 4, 2014

Galena Biopharma to Present at the Noble Financial Capital Markets "X" Tenth Annual Equity Conference

Globe Newswire January 17, 2014

Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources

Accesswire January 14, 2014

Galena Biopharma and Dr. Reddy's Announce Strategic Partnership for NeuVax(TM) in India

Globe Newswire January 14, 2014

Morning Buzzers: Twitter Inc, Apple Inc, Facebook Inc, Galena Biopharma Inc

Accesswire January 13, 2014

Galena Biopharma Acquires Mills Pharmaceuticals, LLC

Globe Newswire January 13, 2014

Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices

Accesswire January 7, 2014

Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer

Globe Newswire January 7, 2014

Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc

Accesswire December 24, 2013

TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE

Accesswire December 5, 2013

Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma

Accesswire December 4, 2013

Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference

Globe Newswire December 4, 2013

TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE

Accesswire December 3, 2013